ISSUE 6 of 6 - In Vitro Diagnostics Business Outlook: Focus on Hematology
Description
The in vitro diagnostics (IVD) sector stands as a cornerstone of modern healthcare, empowering clinicians with the tools to detect diseases, monitor health conditions, and guide precise treatment decisions.
As healthcare evolves, the IVD market is poised for transformative growth. With the rising prevalence of chronic conditions such as diabetes and cardiovascular diseases, as well as ongoing threats from infectious diseases like COVID-19 and emerging variants, the demand for innovative diagnostic solutions has never been greater.
In Vitro Diagnostics Business Outlook is a bimonthly publication, delivering six issues annually, each dedicated to a different segment of the IVD industry. It provides exclusive insights and data, including:
As healthcare evolves, the IVD market is poised for transformative growth. With the rising prevalence of chronic conditions such as diabetes and cardiovascular diseases, as well as ongoing threats from infectious diseases like COVID-19 and emerging variants, the demand for innovative diagnostic solutions has never been greater.
In Vitro Diagnostics Business Outlook is a bimonthly publication, delivering six issues annually, each dedicated to a different segment of the IVD industry. It provides exclusive insights and data, including:
- Market Data and Forecasts: Detailed growth rates, market size, and market share to identify new opportunities.
- Comprehensive Market View: Coverage of test categories and company profiles.
- M&A Activities: Updates on mergers, acquisitions, partnerships, and collaborations.
- Industry & Region Watch: Tailored strategies based on regional and industry-specific trends.
- News Analysis: In-depth reporting on significant news and events, including exclusive information not readily available elsewhere.
Table of Contents
52 Pages
- MARKET ANALYSIS: HEMATOLOGY
- OVERVIEW OF HEMATOLOGY
- MARKET OUTLOOK: HEMATOLOGY
- Table: Global Hematology Testing Market, by Product Segment, 2025-2030 ($ million) [Decentralized (POC) Hematology, Laboratory-based Hematology]
- Figure: Global Hematology Testing Market, by Product Segment, 2025-2030 ($ million) [Decentralized (POC) Hematology, Laboratory-based Hematology]
- Table: Lab-Based and Decentralized Hematology Market Summary, 2025
- Figure: Global Hematology Testing Market, Vendor Share, 2025 (%)
- REGIONAL MARKET
- Table: Hematology Analyzer/Reagent Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, Rest of World]
- Figure: Hematology Analyzer/Reagent Market, by Setting and Region, 2025 ($ million) [Decentralized (POC) Hematology, Laboratory-based Hematology]
- COMPANY BRIEFS
- Danaher
- Roche
- SYSMEX
- EXECUTIVE NEWS BRIEFING
- DETACT DIAGNOSTICS AWARDED $1.6 MILLION
- HEPTA BIO RECEIVES $6.7 MILLION IN SEED FUNDING
- ARCORIS BIO ADVANCES NGS BIOMARKER TECHNOLOGY WITH CHF 6.3 MILLION FUNDING
- CIRCULAR GENOMICS LANDS $15 MILLION SERIES A FINANCING
- BRUKER ADDS NEW BOARD MEMBER
- BILLIONTOONE ONBOARDS CHAIR OF AUDIT COMMITTEE
- AMPLIFOLD RAISES €5 MILLION
- FINANCIAL HIGHLIGHTS: EXACT SCIENCES
- EXACT SCIENCES HIGHLIGHTS CONTINUED GROWTH ACROSS CANCER SCREENING AND ONCOLOGY TESTING IN Q3 2025
- Figure: Exact Sciences Revenue Mix, by Product Segment, Q3 2024 vs Q3 2025 ($ million) [Precision Oncology, Screening]
- Figure: Exact Sciences Revenue Mix, by Product Segment, by Quarter 2020–Q3 2025 ($ million) [COVID-19 Testing, Fecal Occult Screening, Precision Oncology]
- Acquisition Pending – Abbott Laboratories to Acquire Exact Sciences
- Figure: Abbott-Exact Sciences Transaction: Exact Sciences Impact and Business Strategy Outlook
- DIAGNOSTIC MARKET MERGERS, ACQUISITIONS, AND PARTNERSHIP DEALS
- MERGERS AND ACQUISITIONS
- Table: Recent Diagnostic Market Mergers, Acquisitions, and Partnership Deals
- PARTNERSHIPS AND COLLABORATIONS
- INDUSTRY WATCH
- INDUSTRY WATCH COVID-19/FLU UPDATE
- REGION WATCH
- TURKEY
- Figure: Turkey IVD Market Strength and Challenges Profile
- Turkey IVD Market, Estimated Value by Segment, 2025
- BROAD-BASED COMPANY ANNOUNCEMENTS
- SCANOGEN GRANTED FDA BREAKTHROUGH DEVICE DESIGNATION
- BECKTON DICKINSON RECEIVES FDA CLEARANCE AND CE MARKING
- QUIDELORTHO CAPTURES FDA CLEARANCE OR VITROS IMMUNODIAGNOSTIC
- TOSOH BIOSCIENCE SNAGS FDA CLEARANCE
- QIAGEN SET TO ACQUIRE PARSE BIOSCIENCES
- THERMO FISHER GAINS CLEARANCE FOR THE EXENT ANALYZER AND ASSAY
- PROMEGA ONCOMATE WINS FDA APPROVAL
- PROGNOMIQ LAUNCHES LDT
- ROCHE LANDS FDA CLEARANCE WITH CLIA WAIVER FOR NEW POC TEST
- CO-DIAGNOSTICS FORMS NEW AI BUSINESS UNIT
- FDA PROPOSES RECLASSIFICATION OF COMPANION DIAGNOSTIC ASSAYS
- ASTRIN BIOSCIENCES PREPARES TO LAUNCH CERTITUDE BREAST
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
